Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.
Clinical trial NCT01835613 · UNKNOWN
Trial details
- NCT number
- NCT01835613
- Sponsor
- Osservatorio Epidemiologico GISEA
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-07-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.